Healthcare -
Biotechnology - NASDAQ - US
$ 20.905
-4.13 %
$ 1.03 B
Market Cap
-11.13
P/E
ELVN - CASH FROM OPERATIONS
Cash from Operations ELVN - Enliven Therapeutics, Inc.
-73.2 M
LAST VALUE
-51.05%
2 YEAR CAGR
-27.32%
5 YEAR CAGR
0.00%
10 YEAR CAGR